Hanall Biopharma Co., Ltd.

KOSE:A009420 Stock Report

Market Cap: ₩1.8t

Hanall Biopharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Seungwon Jeong

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.6yrs
CEO ownershipn/a
Management average tenure1.6yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Hanall Biopharma Co., Ltd.'s (KRX:009420) 30% Share Price Surge Not Quite Adding Up

Oct 14
Hanall Biopharma Co., Ltd.'s (KRX:009420) 30% Share Price Surge Not Quite Adding Up

Calculating The Intrinsic Value Of Hanall Biopharma Co., Ltd. (KRX:009420)

Jun 26
Calculating The Intrinsic Value Of Hanall Biopharma Co., Ltd. (KRX:009420)

Getting In Cheap On Hanall Biopharma Co., Ltd. (KRX:009420) Is Unlikely

May 22
Getting In Cheap On Hanall Biopharma Co., Ltd. (KRX:009420) Is Unlikely

There May Be Underlying Issues With The Quality Of Hanall Biopharma's (KRX:009420) Earnings

Mar 13
There May Be Underlying Issues With The Quality Of Hanall Biopharma's (KRX:009420) Earnings

Introducing Hanall BiopharmaLtd (KRX:009420), The Stock That Zoomed 103% In The Last Five Years

Feb 12
Introducing Hanall BiopharmaLtd (KRX:009420), The Stock That Zoomed 103% In The Last Five Years

What Kind Of Investors Own Most Of Hanall Biopharma Co.,Ltd (KRX:009420)?

Jan 25
What Kind Of Investors Own Most Of Hanall Biopharma Co.,Ltd (KRX:009420)?

Hanall Biopharma Co.,Ltd's (KRX:009420) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Jan 04
Hanall Biopharma Co.,Ltd's (KRX:009420) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Hanall BiopharmaLtd (KRX:009420) Is Growing Earnings But Are They A Good Guide?

Dec 14
Hanall BiopharmaLtd (KRX:009420) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Hanall BiopharmaLtd (KRX:009420) Is Well Worth Watching

Nov 21
Here's Why We Think Hanall BiopharmaLtd (KRX:009420) Is Well Worth Watching

CEO

Seungwon Jeong

1.6yrs

Tenure

Sean Jeong, also known as Seungwon, M.D., MBA, serves as President & Director at Hanall Biopharma Co.,Ltd since 2021 and is its Co-Chief Executive Officer since April 2023 and was its Chief Executive Offic...


Leadership Team

NamePositionTenureCompensationOwnership
Sean Jeong
President1.6yrsno datano data
Su-Jin Park
Co-CEO, VP & Director1.6yrsno data0.0037%
₩ 67.5m
Christopher Slavinsky
Chief Business Development & Legal Officerless than a yearno datano data
Nam-Yong Cho
Senior Executive Director of Sales & Marketing and Senior Managing Directorno datano datano data

1.6yrs

Average Tenure

Experienced Management: A009420's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Sean Jeong
President3.8yrsno datano data
Su-Jin Park
Co-CEO, VP & Director1.6yrsno data0.0037%
₩ 67.5m
Sung-Hou Kim
Member of Scientific Advisory Boardno datano datano data
Seung-Kook Park
Directorno datano data0.16%
₩ 3.0b
Jae-Ho Cheong
Member of Scientific Advisory Boardno datano datano data
Yong Choi
Member of Scientific Advisory Boardno datano datano data
Aekyung Kim
Member of Scientific Advisory Boardno datano datano data
Young Shin
Member of Scientific Advisory Boardno datano datano data
Jason Song
Member of Scientific Advisory Boardno datano datano data
Jae-chun Yoon
Chairmanno datano datano data
Hun Jung
Independent Director3.8yrsno datano data

3.8yrs

Average Tenure

Experienced Board: A009420's board of directors are considered experienced (3.8 years average tenure).